Identification of p38 MAPK and JNK as new targets for correction of Wilson disease‐causing ATP7B mutants

Abstract

Our findings indicate p38 and c-Jun N-terminal kinase as intriguing targets for correction of WD-causing mutants and, hence, as potential candidates, which could be evaluated for the development of novel therapeutic strategies to combat WD. (Hepatology 2016;63:1842-1859).